Skip to content
  • EnglishEnglish
  • SvenskaSvenska
 

ASCELIA

AN ONCOLOGY-DEDICATED DRUG DEVELOPMENT COMPANY

  • About us
    • Management
    • Board of Directors
  • Diseases
    • Liver metastases
    • Gastric Cancer
  • Pipeline
    • Mangoral
    • Oncoral
  • Partnering
  • IR & Media
    • Press releases
    • Reports & Presentations
    • Share
    • Shareholders
    • Equity research
    • Subscribe to press releases
    • Ascelia Pharma in Media
    • IPO (completed 2019)
    • IR Contact
    • Financial calendar
    • CMD 2020
    • Events
  • Governance
    • General Meeting
    • Articles of Association
    • Nomination Committee
    • Board of Directors
    • Audit Committee
    • Remuneration Committee
    • Commercialization Committee
    • Remuneration
    • Auditors
    • Internal control
  • Career
    • Open positions
    • Open applications
    • Our values
    • Meet us
  • Contact
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
All All press releasesRegulatory press releasesFinancial reports
Regulatory
2021-04-09 | Issue and repurchase of series C shares for share saving program
Download
Presentation
Webcast
Excel
Regulatory
2021-03-31 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB
Download
Presentation
Webcast
Excel
Regulatory
2021-03-31 | Number of shares and votes in Ascelia Pharma AB
Download
Presentation
Webcast
Excel
Regulatory
2021-03-30 | Ascelia Pharma publishes Annual Report for 2020
Download
Presentation
Webcast
Excel
Regulatory
2021-03-17 | Notice of extraordinary general meeting in Ascelia Pharma
Download
Presentation
Webcast
Excel
Regulatory
2021-03-17 | Ascelia Pharma has carried out a directed new share issue raising SEK 200 million
Download
Presentation
Webcast
Excel
Regulatory
2021-03-17 | Ascelia Pharma intends to carry out a directed new share issue
Download
Presentation
Webcast
Excel
2021-03-02 | Ascelia Pharma opens US office in preparation for Mangoral launch
Download
Presentation
Webcast
Excel
Regulatory
2021-02-16 | Quarterly Report Q4 2020: Mangoral shows high diagnostic value in new study
Download
Presentation
Webcast
Excel
2021-01-14 | Information regarding transfer of shares in Ascelia Pharma AB from CMC SPV
Download
Presentation
Webcast
Excel
2021-01-12 | Ascelia Pharma presents clinical development plan for Oncoral as a novel chemotherapy
Download
Presentation
Webcast
Excel
Regulatory
2020-12-15 | Ascelia Pharma gets US patent for second generation Mangoral
Download
Presentation
Webcast
Excel
Regulatory
2020-12-02 | New study shows Mangoral’s lesion visualization as effective as gadolinium contrast agent
Download
Presentation
Webcast
Excel
Regulatory
2020-11-05 | Quarterly Report Q3-2020: Raised market estimate for Mangoral and preparing for market launch
Download
Presentation
Webcast
Excel
2020-11-03 | EMA confirms Mangoral eligible for the centralized regulatory procedure in the EU
Download
Presentation
Webcast
Excel
Regulatory
2020-10-21 | Upgraded estimate of addressable market for Mangoral to $500-600 million annually
Download
Presentation
Webcast
Excel
2020-09-30 | Invitation to Ascelia Pharma’s virtual Capital Markets Day
Download
Presentation
Webcast
Excel
2020-09-18 | First commercial scale manufacturing of Mangoral
Download
Presentation
Webcast
Excel
Regulatory
2020-08-20 | Quarterly Report Q2-2020: First participant in the hepatic study
Download
Presentation
Webcast
Excel
Regulatory
2020-07-31 | Change in number of shares and votes in Ascelia Pharma AB
Download
Presentation
Webcast
Excel

Posts navigation

Older posts

  • Ascelia Pharma AB

  • Hyllie Boulevard 34

  • 215 32 MALMÖ

  • Sweden

  • +46 735 179 118

Ascelia Pharma © 2019 | All Rights Reserved

Privacy policy Ascelia Pharma AB

Video
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
  • Necessary
    These cookies are not optional. They are needed for the website to function.
  • Statistics
    In order for us to improve the website's functionality and structure, based on how the website is used.
  • Experience
    In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
  • Marketing
    By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.
Save Accept all